START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, liposarcoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, myxoid liposarcoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, osteosarcoma, primitive neuroectodermal tumor, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm, synovial sarcoma, triple-negative breast carcinoma	Recruiting	Phase 1	2026-05-12		NCT05492682

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Valo Therapeutics Oy	1

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
IRCCS Istituto Clinico Humanitas	Milan	Italy	3
IRCCS Ospedale San Raffaele	Milan	Italy	47
Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS	Candiolo	Italy	1
Krankenhaus Nordwest	Frankfurt	Germany	5
National Center for Tumor Diseases	Heidelberg	Germany	2
Università di Napoli Federico II	Naples	Italy	1
Universitätsklinikum Tübingen	Tübingen	Germany	11